MYGN Stock Summary

• The price/operating cash flow metric for Myriad Genetics Inc is higher than 80.62% of stocks in our set with a positive cash flow.
• MYGN's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 21.34% of US stocks.
• In terms of twelve month growth in earnings before interest and taxes, Myriad Genetics Inc is reporting a growth rate of -128.77%; that's higher than merely 10.89% of US stocks.
• Stocks that are quantitatively similar to MYGN, based on their financial statements, market capitalization, and price volatility, are CSPI, VNET, RST, IIN, and VG.
• Visit MYGN's SEC page to see the company's official filings. To visit the company's web site, go to myriad.com.